Is There A Better Place To Decide What’s Right For Patients? Is There A Better Place To Decide What’s Right For Patients?
Dr. Robert Califf Shares Ideas About Real-World Evidence And Health Data Dr. Robert Califf Shares Ideas About Real-World Evidence And Health Data
A PARP Inhibitor Keeps Some Cancers In Check For Years A PARP Inhibitor Keeps Some Cancers In Check For Years
A New Antibody For Treating Acute Lymphocytic Leukemia? A New Antibody For Treating Acute Lymphocytic Leukemia?
Encouraging Results For Ribociclib In Advanced Breast Cancer Encouraging Results For Ribociclib In Advanced Breast Cancer
Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game Tragedy In A Clinical Trial: A Reminder That Biotech Is Not A Game
A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer A Novel, Targeted Drug Yields Promising Results In Stomach And Esophageal Cancer
Report Touts Benefits Of Prolonged Medication After Breast Cancer. Is It Persuasive? Report Touts Benefits Of Prolonged Medication After Breast Cancer. Is It Persuasive?
The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology The Emerging Value Of Personalized Phase 1 Clinical Trials In Oncology
The Big News For Sickle Cell Anemia Is Not Gene Therapy The Big News For Sickle Cell Anemia Is Not Gene Therapy
Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value Why Evidence From A Clinical Trial Of Ovarian Cancer Has Limited Value
In Lumpectomy For Breast Cancer, Taking Out A Bit More Reduces O.R. Revisits In Lumpectomy For Breast Cancer, Taking Out A Bit More Reduces O.R. Revisits
What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer What’s Intriguing And Concerning About Early Results For Keytruda In Breast Cancer
Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer Ambitious ‘Lung-MAP’ Trial Aims to Evaluate Biomarkers and New Drugs in Squamous Cell Lung Cancer
What’s Missing in the Recent Mammography Value Study What’s Missing in the Recent Mammography Value Study
